Vanguard Group
GH icon

Vanguard Group’s Guardant Health GH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$633M Buy
12,168,020
+86,643
+0.7% +$4.51M 0.01% 899
2025
Q1
$515M Buy
12,081,377
+28,826
+0.2% +$1.23M 0.01% 975
2024
Q4
$368M Buy
12,052,551
+350,606
+3% +$10.7M 0.01% 1221
2024
Q3
$268M Buy
11,701,945
+65,213
+0.6% +$1.5M ﹤0.01% 1383
2024
Q2
$336M Buy
11,636,732
+200,706
+2% +$5.8M 0.01% 1202
2024
Q1
$236M Buy
11,436,026
+305,372
+3% +$6.3M ﹤0.01% 1409
2023
Q4
$301M Buy
11,130,654
+180,424
+2% +$4.88M 0.01% 1287
2023
Q3
$325M Buy
10,950,230
+146,902
+1% +$4.35M 0.01% 1162
2023
Q2
$387M Buy
10,803,328
+1,569,545
+17% +$56.2M 0.01% 1084
2023
Q1
$216M Buy
9,233,783
+193,543
+2% +$4.54M 0.01% 1408
2022
Q4
$246M Buy
9,040,240
+124,674
+1% +$3.39M 0.01% 1324
2022
Q3
$480M Buy
8,915,566
+74,247
+0.8% +$4M 0.01% 859
2022
Q2
$357M Buy
8,841,319
+90,319
+1% +$3.64M 0.01% 1064
2022
Q1
$580M Sell
8,751,000
-11,086
-0.1% -$734K 0.01% 875
2021
Q4
$876M Buy
8,762,086
+57,156
+0.7% +$5.72M 0.02% 713
2021
Q3
$1.09B Buy
8,704,930
+77,430
+0.9% +$9.68M 0.03% 607
2021
Q2
$1.07B Buy
8,627,500
+486,607
+6% +$60.4M 0.03% 629
2021
Q1
$1.24B Buy
8,140,893
+519,656
+7% +$79.3M 0.03% 546
2020
Q4
$982M Buy
7,621,237
+1,094,241
+17% +$141M 0.03% 593
2020
Q3
$730M Buy
6,526,996
+207,731
+3% +$23.2M 0.02% 626
2020
Q2
$513M Buy
6,319,265
+2,144,771
+51% +$174M 0.02% 751
2020
Q1
$291M Buy
4,174,494
+107,362
+3% +$7.47M 0.01% 911
2019
Q4
$318M Buy
4,067,132
+711,112
+21% +$55.6M 0.01% 1093
2019
Q3
$214M Buy
3,356,020
+462,200
+16% +$29.5M 0.01% 1292
2019
Q2
$250M Buy
2,893,820
+1,741,472
+151% +$150M 0.01% 1219
2019
Q1
$88.4M Buy
1,152,348
+18,893
+2% +$1.45M ﹤0.01% 1812
2018
Q4
$42.6M Buy
+1,133,455
New +$42.6M ﹤0.01% 2111